Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 0.5000
-0.0600 (-10.71%)
Sep 8, 2026, 1:36 PM EST
Onco-Innovations Revenue
In the fiscal year ending April 30, 2026, Onco-Innovations had annual revenue of 110.38K CAD with 69.06% growth. Onco-Innovations had revenue of 21.00K in the quarter ending April 30, 2026, a decrease of -67.84%.
Revenue
110.38K
Revenue Growth
+69.06%
P/S Ratio
309.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
34.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 110.38K | 45.09K | 69.06% |
| Apr 30, 2025 | 65.29K | - | - |
| Apr 30, 2024 | - | - | - |
| Apr 30, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Onco-Innovations News
- 14 hours ago - Onco-Innovations Announces Shares for Debt Settlement - TheNewswire
- 20 days ago - Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program - Accesswire
- 27 days ago - Onco-Innovations Advances ONC010 Polymer Development with Identification of Non-Tin Catalyst and Provides Integrated Update - TheNewswire
- 5 weeks ago - Onco-Innovations Reports Progress Toward a Consistent and Scalable Polymer Manufacturing Process Supporting ONC010 - TheNewswire
- 5 weeks ago - Onco-Innovations Announces Initial Closing of Notional CAD$5 Million Performance-Based Funding Arrangement - TheNewswire
- 6 weeks ago - Onco-Innovations Announces Repricing of Previously Announced Performance-Based Funding Arrangement - TheNewswire
- 7 weeks ago - Onco-Innovations Initiates ADME Studies Supporting Development of ONC010 - TheNewswire
- 7 weeks ago - Onco-Innovations Announces Entry into Loan Agreements - TheNewswire